INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 42h ago
HOUSE PTR2h ago
SEC 13F2h ago
ROBINHOOD CHAIN2h ago
Corporate insider
RJ

Riley Jennifer

Chief Strategy OfficerCIK 0002047607

EDGAR filingsOpen in network
Disclosed transactions4
Buys / sells0 / 1
Max Insider Score38
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
38
RJ
Riley JenniferChief Strategy Officer
AVTXAvalo Therapeutics, Inc.
Open-market sale
SELL$52K
2,655 sh
Aug 11, 2026Aug 12, 2026
traded Aug 11, 2026
+1dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Avalo Therapeutics, Inc.Chief Strategy Officer · Mar 2, 2026
9
RJ
Riley JenniferChief Strategy Officer
AVTXAvalo Therapeutics, Inc.
Tax withholding
F
$7,703
588 sh
Jun 10, 2026
Jun 12, 2026
traded Jun 10, 2026
+2d
SEC FORM 4

Evidence

27
RJ
Riley JenniferChief Strategy Officer
AVTXAvalo Therapeutics, Inc.
Grant or award
A—
34.2K sh
May 21, 2026May 26, 2026
traded May 21, 2026
+5dSEC FORM 4

Evidence

9
RJ
Riley JenniferChief Strategy Officer
AVTXAvalo Therapeutics, Inc.
Grant or award
A—
95.0K sh
Feb 26, 2026Mar 2, 2026
traded Feb 26, 2026
+4dSEC FORM 4

Evidence